Positron emission tomography (PET) is a highly valuable
imaging
technique with many clinical applications. The possibility to study
physiological and biochemical processes in vivo also makes PET an
important tool in drug discovery. Of importance is the possibility
of labelling the compound of interest with a positron-emitting radionuclide,
such as carbon-11. Carbonylation reactions with [11C]carbon
monoxide ([11C]CO) has been used to label a number of molecules
containing a carbonyl derivative, such as amides and esters, with
carbon-11. Presented herein is the palladium-mediated carbonylative
synthesis of [carbonyl-11C]acyl amidines and their subsequent
cyclization to 11C-labeled 1,2,4-oxadiazoles. Starting
from amidines, [11C]CO, and either aryl iodides or aryl
bromides, [carbonyl-11C]acyl amidines were synthesized
and isolated in good to very good radiochemical yields (RCY). The 11C-labeled 1,2,4-oxadiazoles were synthesized without the
isolation of the intermediate [carbonyl-11C]acyl amidines
and isolated in useful RCYs, including the NF-E2-related factor 2
activator DDO-7263. 3-Phenyl-5-(4-tolyl)-1,2,4-(5-11C)oxadiazole
was synthesized and isolated with a clinically relevant molar activity.
The broadened substrate scope, together with the good RCY and high A
m, demonstrates the utility of this method for
the incorporation of carbon-11 into acyl amidines and 1,2,4-oxadiazoles,
structural motifs of pharmacological interest.